Assessment of the individual determinants of two fibrinolysis assays, GFC and ECLT in platelet-depleted plasma and derived euglobulin fraction respectively

Marion Bareille; Thomas Lecompte; François Mullier

doi:10.1016/j.thromres.2023.08.008

Assessment of the individual determinants of two fibrinolysis assays, GFC and ECLT in platelet-depleted plasma and derived euglobulin fraction respectively

Thromb Res. 2023 Oct:230:33-36. doi: 10.1016/j.thromres.2023.08.008. Epub 2023 Aug 13.

Authors

Marion Bareille¹, Thomas Lecompte², François Mullier³

Affiliations

¹ Université catholique de Louvain, CHU UCL Namur, Hematology Laboratory, Yvoir, Belgium. Electronic address: marion.bareille@uclouvain.be.
² Université de Lorraine, Nancy, France; Université de Namur, Department of Pharmacy, Namur Thrombosis and Hemostasis Center (NTHC), Namur Research Institute for Life Sciences (NARILIS), Namur, Belgium.
³ Université catholique de Louvain, CHU UCL Namur, Namur Thrombosis and Hemostasis Center (NTHC), Namur Research Institute for Life Sciences (NARILIS), Hematology Laboratory, Yvoir, Belgium.

PMID: 37633059
DOI: 10.1016/j.thromres.2023.08.008

No abstract available

Keywords: Bleeding of unknown cause; Euglobulin clot lysis time; Fibrinolysis; Fibrinolysis inhibitors; Global fibrinolytic capacity; Lysis timer; Mild bleeding disorder.

Publication types

Letter